COSMOS Pharmaceutical Corporation (3349.T)

9053.0035.00 (-0.39%)

COSMOS Pharmaceutical Corporation (3349.T) stock comprehensive Profitability Analysis including gross margin, operating margin, net margin, return on assets, return on equity, return on invested capital. Compare profitability against peers/competitors, industry and sector standards.

Low Bankruptcy RiskLow ProfitabilityEfficient OperationsModerate GrowthModerate QualityAdequate Dividend ProfileIndustry Rank: 67.57%Sector Rank: 75.68%

JPX - Healthcare - Medical - Pharmaceuticals | Market Cap: 717.52B | Next Earnings Date: 14 Oct 2025

Day's Range

8935.00 - 9125.00

52-Week Range

6347.00 - 10045.00

Volume

380.0K / 335.9K (Avg.)

P/E Ratio | EPS

23.15 | 391.09

Trending:

3349.T Profitability Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Profitability reveals how effectively the business turns revenues into profits. Higher and improving margins or returns on capital suggest a durable competitive advantage, supporting a stronger intrinsic valuation.

Return on Equity (ROE)

5.63%

Increased from previous period

ROE 5-10% – Below desirable range. Philip Fisher would scrutinize management efficiency. Verify future expansion plans.

Return on Assets (ROA)

2.06%

Increased from previous period

ROA 2-5% – Weak asset utilization. Howard Marks would question if structural changes are needed.

Return on Capital Employed (ROCE)

8.22%

Increased from previous period

ROCE 5-10% – Weak efficiency. Howard Marks would question if management can boost profitability.

Gross Profit Margin

18.53%

Decreased from previous period

Gross margin 10-20% – Weak. Howard Marks would demand clarity on why margins are compressed.

Operating Profit Margin

4.44%

Decreased from previous period

Operating margin under 5% – Very weak. Philip Fisher would demand significant cost restructuring or product differentiation.

Net Profit Margin

2.68%

Increased from previous period

Net margin below 3% – Very thin. Peter Lynch would demand a strategic shift or new growth drivers.

Select Chart Metric:

3349.T Profitability Analysis

Compare against a Competitor

None 3391.T 3141.T 3088.T 2127.T 9843.T

Return on Equity (ROE)

5.63%

Increased from previous period

ROE 5-10% – Below desirable range. Philip Fisher would scrutinize management efficiency. Verify future expansion plans.

Return on Assets (ROA)

2.06%

Increased from previous period

ROA 2-5% – Weak asset utilization. Howard Marks would question if structural changes are needed.

Return on Capital Employed (ROCE)

8.22%

Increased from previous period

ROCE 5-10% – Weak efficiency. Howard Marks would question if management can boost profitability.

Gross Profit Margin

18.53%

Decreased from previous period

Gross margin 10-20% – Weak. Howard Marks would demand clarity on why margins are compressed.

Operating Profit Margin

4.44%

Decreased from previous period

Operating margin under 5% – Very weak. Philip Fisher would demand significant cost restructuring or product differentiation.

Net Profit Margin

2.68%

Increased from previous period

Net margin below 3% – Very thin. Peter Lynch would demand a strategic shift or new growth drivers.

Select Chart Metric: